WHO ICTRP trial
Multicenter, randomized, investigator-masked study comparing brimonidine…
JPRN-UMIN000014810 · Japan Primary Registries Network (JPRN) · Not Recruiting
Key facts
| Trial ID | JPRN-UMIN000014810 |
|---|---|
| Public title | Multicenter, randomized, investigator-masked study comparing brimonidine tartrate 0.1% and timolol maleate 0.5% as adjunctive therapies to prostaglandin analogs in normal tension glaucoma |
| Scientific title | Multicenter, randomized, investigator-masked study comparing brimonidine tartrate 0.1% and timolol maleate 0.5% as adjunctive therapies to prostaglandin analogs in normal tension glaucoma - Assessment of AIPHAGAN Addition in PG treated NTG (AAA-study) |
| Primary sponsor | AAA study group |
| Secondary sponsors | Tokyo Teishin Hospital Kinki University |
| Registry | Japan Primary Registries Network (JPRN) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Phase | Not applicable |
| Countries | Japan |
| Conditions | Normal Tension Glaucoma |
| Interventions | 0.1%Brimonidine Tartrate, b.i.d. for 12weeks 0.5%Timolol Maleate, b.i.d. for 12weeks |
| Registration date | Oct 8, 2014 |
| Target size | 144 |
| Registry page | center6.umin.ac.jp |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: